Ibm Retirement Fund Sarepta Therapeutics, Inc. Transaction History

Ibm Retirement Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$77.28 - $99.42 $168,547 - $216,835	-2,181 Closed	0 $0
Q3 2021 Oct 05, 2021	BUY	$65.97 - $92.48 $143,880 - $201,698	2,181 New	2,181 $202,000
Q1 2021 Apr 22, 2021	SELL	$72.25 - $168.95 $198,687 - $464,612	-2,750 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$125.56 - $178.74 $41,685 - $59,341	332 Added 13.73%	2,750 $469,000
Q3 2020 Oct 16, 2020	BUY	$127.12 - $172.34 $86,314 - $117,018	679 Added 39.05%	2,418 $340,000
Q2 2020 Jul 08, 2020	BUY	$93.0 - $171.7 $161,727 - $298,586	1,739 New	1,739 $279,000

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.